These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15849330)

  • 1. The GOAL study: designed to favor a long-acting beta2-agonist?
    Currie GP; Lee DK
    Am J Respir Crit Care Med; 2005 May; 171(9):1060-1; author reply 1061. PubMed ID: 15849330
    [No Abstract]   [Full Text] [Related]  

  • 2. An own GOAL or a real breakthrough?
    Fardon TC; Lipworth BJ
    Am J Respir Crit Care Med; 2005 May; 171(9):1060; author reply 1061. PubMed ID: 15849331
    [No Abstract]   [Full Text] [Related]  

  • 3. The current landscape of asthma: a new geometry.
    Wolf BL
    Ann Allergy Asthma Immunol; 2002 Oct; 89(4):337-9. PubMed ID: 12392373
    [No Abstract]   [Full Text] [Related]  

  • 4. Dual components of optimal asthma therapy: scientific and clinical rationale for the use of long-acting beta-agonists with inhaled corticosteroids.
    Naedele-Risha R; Dorinsky P; Craig TJ
    J Am Osteopath Assoc; 2001 Sep; 101(9):526-33. PubMed ID: 11575039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy with a long-acting beta2-agonist and an inhaled corticosteroid as initial maintenance treatment in asthma.
    Lee DK; Currie GP; Lipworth BJ
    Ann Allergy Asthma Immunol; 2005 Mar; 94(3):410-1; author reply 411-2. PubMed ID: 15801257
    [No Abstract]   [Full Text] [Related]  

  • 6. Should combination therapy with inhaled corticosteroids and long-acting beta2-agonists be prescribed as initial maintenance treatment for asthma?
    Lemière C; Becker A; Boulet LP; Bowie D; Cartier A; Cockroft D; Cowie R; Ernst P; Fitzgerald M; Sears M; Spier S
    CMAJ; 2002 Oct; 167(9):1008-9. PubMed ID: 12403741
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of fluticasone propionate-salmeterol combination therapy and montelukast in patients who are symptomatic on short-acting beta(2)-agonists alone.
    Calhoun WJ; Nelson HS; Nathan RA; Pepsin PJ; Kalberg C; Emmett A; Rickard KA; Dorinsky P
    Am J Respir Crit Care Med; 2001 Sep; 164(5):759-63. PubMed ID: 11549529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An antiinflammatory effect of salmeterol, a long-acting beta(2) agonist, assessed in airway biopsies and bronchoalveolar lavage in asthma.
    Li X; Ward C; Thien F; Bish R; Bamford T; Bao X; Bailey M; Wilson JW; Haydn Walters E
    Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1493-9. PubMed ID: 10556111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone.
    Bousquet J; Boulet LP; Peters MJ; Magnussen H; Quiralte J; Martinez-Aguilar NE; Carlsheimer A
    Respir Med; 2007 Dec; 101(12):2437-46. PubMed ID: 17905575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-acting beta 2-agonists and their role in asthma management.
    Galant SP
    West J Med; 1995 Oct; 163(4):372. PubMed ID: 7483600
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhaled corticosteroid therapy in asthma: a balancing act.
    Li JT
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):229-30. PubMed ID: 10094213
    [No Abstract]   [Full Text] [Related]  

  • 13. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
    Murray J; Rosenthal R; Somerville L; Blake K; House K; Baitinger L; VanderMeer A; Dorinsky P
    Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of obesity on response to fluticasone with or without salmeterol in moderate asthma.
    Boulet LP; Franssen E
    Respir Med; 2007 Nov; 101(11):2240-7. PubMed ID: 17686624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stopping long-acting beta-2 agonists.
    Med Lett Drugs Ther; 2010 Mar; 52(1334):21. PubMed ID: 20336032
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-acting bronchodilators in premenstrual exacerbation of asthma.
    Magadle R; Berar-Yanay N; Weiner P
    Respir Med; 2001 Sep; 95(9):740-3. PubMed ID: 11575895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefit from anti-inflammatory treatment during clinical remission of atopic asthma.
    van den Toorn LM; Prins JB; de Jongste JC; Leman K; Mulder PG; Hoogsteden HC; Overbeek SE
    Respir Med; 2005 Jun; 99(6):779-87. PubMed ID: 15878496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. beta-adrenergic receptor genotype and response to salmeterol.
    Wechsler ME; Israel E
    J Allergy Clin Immunol; 2007 Jul; 120(1):218-9; author reply 219-20. PubMed ID: 17399776
    [No Abstract]   [Full Text] [Related]  

  • 19. Newer therapeutic agents for asthma.
    Deykin A; Israel E
    Adv Intern Med; 1999; 44():209-37. PubMed ID: 9929710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-acting beta agonists--prescribe with care.
    Crane J
    N Z Med J; 2006 Jul; 119(1237):U2064. PubMed ID: 16862206
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.